Home » News » CROs/Service Providers » Quintiles closes Novella Clinical acquisition

Quintiles closes Novella Clinical acquisition

Monday, September 23, 2013

Global CRO Quintiles has completed its previously announced acquisition of Novella Clinical, a full-service CRO focused primarily on emerging oncology as well as medical devices and diagnostics.

Paula Brown Stafford, president, clinical development at Quintiles, said, “With the transaction now officially closed, we will focus our efforts on leveraging Quintiles’ global resources and capabilities with the expertise and personal attention of Novella.”

Now known as “Novella Clinical, a Quintiles company,” Novella will operate as a unit within Quintiles, retaining its existing leadership team.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!